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Abstract
Background: In animal studies tumor size is used to assess responses to anticancer therapy.
Current standard for volumetric measurement of xenografted tumors is by external caliper, a
method often affected by error. The aim of the present study was to evaluate if microCT gives
more accurate and reproducible measures of tumor size in mice compared with caliper
measurements. Furthermore, we evaluated the accuracy of tumor volume determined from 18F-
fluorodeoxyglucose (18F-FDG) PET.
Methods: Subcutaneously implanted human breast adenocarcinoma cells in NMRI nude mice
served as tumor model. Tumor volume (n = 20) was determined in vivo by external caliper,
microCT and 18F-FDG-PET and subsequently reference volume was determined ex vivo. Intra-
observer reproducibility of the microCT and caliper methods were determined by acquiring 10
repeated volume measurements. Volumes of a group of tumors (n = 10) were determined
independently by two observers to assess inter-observer variation.
Results: Tumor volume measured by microCT, PET and caliper all correlated with reference
volume. No significant bias of microCT measurements compared with the reference was found,
whereas both PET and caliper had systematic bias compared to reference volume. Coefficients of
variation for intra-observer variation were 7% and 14% for microCT and caliper measurements,
respectively. Regression coefficients between observers were 0.97 for microCT and 0.91 for
caliper measurements.
Conclusion:  MicroCT was more accurate than both caliper and 18F-FDG-PET for in vivo
volumetric measurements of subcutaneous tumors in mice.18F-FDG-PET was considered
unsuitable for determination of tumor size. External caliper were inaccurate and encumbered with
a significant and size dependent bias. MicroCT was also the most reproducible of the methods.
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Background
Measurement of tumor size is important in preclinical
animal studies when assessing responses to cancer treat-
ment. In longitudinal studies, sequential measurements
of tumor volume with a non-invasive method are essen-
tial. Current standard technique for volume determina-
tion of subcutaneously xenografted tumors in vivo is by
external caliper where tumor volume is calculated by use
of the modified ellipsoid formula 1/2(Length ×
Width2)[1,2]. However, measurements using caliper are
often affected by errors due to e.g. variability in tumor
shape, skin thickness and subcutaneous fat layer thick-
ness. Furthermore, observer subjectivity and differences in
the compressibility of the tumor can easily lead to varia-
tion in measurements. Clinically, computed tomography
(CT) and positron emission tomography (PET) are widely
used to monitor response to treatment [3]. Preclinical
imaging with microCT and microPET has in recent years
become more widespread [4-8].
The aim of the present study was therefore to evaluate if
microCT gives more accurate and reproducible measures
of tumor volume in in vivo studies of subcutaneous
xenografted tumors compared with standard caliper
measurements. Furthermore, we evaluated the accuracy of
tumor volume determined from 18F-fluorodeoxyglucose
(18F-FDG) PET. To do so, we compared the microCT, PET
and caliper methods for tumor volume determination,
with ex vivo measurements as reference, and quantified
inter- and intra-observer variation for the microCT and
caliper methods.
Methods
Tumor Model
Six weeks old female NMRI (Naval Medical Research Insti-
tute) nude mice were acquired from Taconic Europe (Lille
Skensved, Denmark) and allowed to acclimate one week
in the animal facility before any intervention was initi-
ated. All experimental procedures were conducted with
the guidelines set forth by the Danish Ministry of Justice.
Estrogen pellets, 0.72 mg 17-β-Estradiol, 60-day release
(Innovative Research of America, Sarasota, FL, USA), were
implanted s.c. during anesthesia with 1:1 v/v mixture of
Hypnorm® (Janssen Pharmaceutica, Beerse, Belgium) and
Dormicum® (Roche, Basel, Switzerland). One week after
implantation of pellets, MCF-7 (human breast adenocar-
cinoma) tumor cells (107 cells in 100 μL medium mixed
with 100 μL Matrixgel™ Basement Membrane Matrix (BD
Biosciences, San Jose, CA, USA)) were injected subcutane-
ous into the left and right flank respectively. Cells were
cultured in Dulbecco's Modified Eagle Medium (DMEM)
medium supplemented with 10% fetal calf serum and 1%
penicillin-streptomycin in 5% CO2 at 37°C.
Volume Determination
Three weeks after implantation of tumor cells (tumor size
20 – 250 mm3) volumes of 20 tumors were determined in
vivo by external caliper, microCT and 18F-FDG-PET. Subse-
quently, tumors were excised and reference tumor volume
was calculated from weight and density (1.05 g/mL).
In order to assess the intra- and inter-observer variation
on the microCT and caliper volume measurements two
additional experiments were carried out. To determine the
intra-observer reproducibility, volume of two tumors was
determined by acquiring 10 microCT scans and 10 caliper
determinations of each tumor. In addition, volumes of a
group of 10 tumors were determined independently by
two different observers to assess inter-observer variation.
Each of the 10 mice had one microCT scan performed and
region of interests (ROIs) were subsequently drawn cover-
ing the tumors independently by each of the two observ-
ers.
Measurement by Caliper
In order to determine tumor volume by external caliper,
the greatest longitudinal diameter (length) and the great-
est transverse diameter (width) were determined. Tumor
volume based on caliper measurements were calculated
by the modified ellipsoidal formula [1,2]
Tumor volume = 1/2(length × width2)
18F-FDG microPET imaging and microCT imaging
Mice were injected i.p or i.v with 8.7 ± 1.7 (mean ± SD)
MBq of 18F-FDG. 18F-FDG was produced at our own facil-
ities (Rigshospitalet, Copenhagen, Denmark). One hour
after 18F-FDG injection mice were anaesthetized with 3%
sevofluran (Abbott Scandinavia AB, Solna, Sweden)
mixed with 35% O2 in N2 and fixed on a bed. A 20 min
PET scan was acquired using a MicroPET Focus 120 (Sie-
mens Medical Solutions, Malvern, PA, USA). After data
acquisition, PET data were arranged into sinograms and
subsequently reconstructed with the Ordered Subset
Expectation Maximization 2D (OSEM2D) reconstruction
algorithm. The pixel size was 0.866 × 0.866 × 0.796 mm
and in the center field of view the resolution was 1.4 mm
full-width-at-half-maximum.
Following the microPET scan, a microCT scan was
acquired with a MicroCAT® II system (Siemens Medical
solutions). A 7 minute and 10 seconds CT scan was per-
formed with parameter settings: 360 rotation steps, tube
voltage 60 kV, tube current 500 μA, binning 4 and expo-
sure time 310 ms. The pixel size was 0.081 × 0.081 × 0.081
mm.
PET and microCT images were separately analyzed with
the Inveon software (Siemens). ROIs were drawn manu-BMC Medical Imaging 2008, 8:16 http://www.biomedcentral.com/1471-2342/8/16
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ally by qualitative assessment covering the entire tumor
and tumor volume was generated by summation of voxels
within the tomographic planes.
Statistical analysis
Analysis of tumor volumes obtained by the three different
methods was performed by linear regression for each
method against reference tumor volume. Agreement
between the PET, microCT and caliper methods against
reference tumor volume was further analyzed by means of
Bland-Altman plots where the central line (mean) indi-
cates the bias and the outer lines (± 2SD) indicate the lim-
its of agreements (LoA) [9]. The 95% confidence interval
(CI) on bias was calculated, and bias was considered sig-
nificant if 0 was not included in the CI.
In order to assess the intra-observer variation, coefficient
of variation (CV) for the 10 repeated microCT and caliper
measurements were calculated. Tumor volumes measured
by two experienced observers were evaluated my means of
linear regression, correlation coefficients and Bland-Alt-
man plots in order to determine the inter-observer varia-
tion.
Results
Tumor volume determined by microCT, 18F-FDG-PET and 
external caliper
Tumor volume measured by microCT, PET and caliper all
correlated (P < 0.001) with reference volume (figure 1).
MicroCT versus reference volume (n = 20) had the best fit
of line y = 1.01 ± 0.04x - 6.1 ± 6.3 (R2 = 0.97; p < 0.001).
Since 2 tumors were unidentifiable on the PET scan only
18 tumors were available for comparison of 18F-FDG-PET
with reference volume. The tumors used in the study did
not contain necrotic elements. The best line for 18F-FDG-
PET versus reference volume was y = 1.24 ± 0.18x + 15.4 ±
30.4 (R2 = 0.75; p < 0.001). Caliper versus reference vol-
ume (n = 20) had the best fit of line y = 1.27 ± 0.15x + 56.9
± 24.2 (R2 = 0.80; p < 0.001). An example of ROIs drawn
in the microCT and PET pictures is shown in figure 2.
Bland-Altman plots of volume measured by microCT, PET
and caliper versus reference tumor volume are shown in
figure 3.
The mean difference between microCT and reference
tumor volume was -5.1 mm3 (95% CI on difference: -
10.6-0.3 mm3; LoA: -29.6-19.4 mm3). Accordingly, no sig-
nificant bias of microCT measurements compared with
the reference was found. The mean difference between
PET and reference tumor volume was 52.1 mm3 (95% CI
on difference: 28.0–73.3 mm3; LoA: -50.4–154.7 mm3)
and between caliper and reference tumor volume it was
95.1 mm3 (95% CI on difference: 71.6–118.6 mm3; LoA:
-10.0–200.3 mm3). Accordingly, both PET and caliper
had systematic bias when compared to reference volume.
The average overestimate of volume using PET was 52
mm3 (35%) and overestimation of volume by using cali-
per was 95 mm3 (86%).
Intra- and inter-observer variation
Intra-observer variation expressed as CV was on average
7% (83.4 ± 6.9 mm3, n = 10; 93.4 ± 6.1 mm3, n = 10;
mean ± SD) for the microCT method and 14% (102.4 ±
17.4 mm3, n = 10; 167.3 ± 18.0 mm3, n = 10; mean ± SD)
for the caliper method.
Inter-observer variation expressed as correlations of
tumor volume determined by the two observers are
shown in figure 4. Correlation coefficients (R2) were 0.97
for microCT and 0.91 for caliper measurements (n = 10).
Bland-Altman plots of the difference between two observ-
ers against mean volume are shown in figure 5.
The mean difference between observers for caliper meas-
urements was -9.8 mm3 (95% CI on difference: -24.5-4.9
mm3; LoA: -56.3-36.7 mm3) and for microCT measure-
ments it was 0.0 mm3 (95% CI on difference: -5.9-5.9
mm3; LoA: -18.6-18.6 mm3). Accordingly, no systematic
bias was found between observers.
Discussion
Most cancer treatment studies assess drug effect by
sequential measurements of tumor volume. Currently, the
standard method for non-invasive volume measurements
of subcutaneous tumors in mice is with external caliper.
This is a somewhat subjective method often affected by
much error [1] and accordingly there is a need for more
accurate volume measurements. Non-invasive imaging
modalities such as ultrasonography and MRI have been
investigated for their ability to follow tumors in mice dur-
ing longitudinal studies in vivo [10,11]. Ultrasonography
and MRI were both shown to be valuable tools for esti-
mating volume of small tumor masses. Ultrasonography
has the advantage of having a relative low cost of equip-
ment and both MRI and ultrasonography have the advan-
tage that they do not impose any radiation dose that may
interfere with tumor growth. Further, it has been shown
that CT as part of a clinical PET/CT scanner can determine
volume more precisely than traditional caliper measure-
ments of large subcutaneous tumors in rats [12]. Preclini-
cal imaging of small animals with dedicated animal
microCT and microPET scanners has in recent years
become available and could be even better alternatives for
tumor volume determination. Accordingly, we evaluated
the capability of these modalities for volume determina-
tion of subcutaneous tumors in mice.
We found that the microCT method was altogether more
accurate than both PET and caliper methods for determi-BMC Medical Imaging 2008, 8:16 http://www.biomedcentral.com/1471-2342/8/16
Page 4 of 9
(page number not for citation purposes)
nation of tumor volume. For the microCT method there
was no systematic bias, whereas both the PET and caliper
method systematically overestimated tumor size. The bias
of the caliper measurements was smaller for small tumors
compared to greater tumors also relatively seen. Conse-
quently, volume changes measured with caliper in small
and large tumors are not comparable and effects of anti-
cancer drugs can easily be missed as tumors will tend
towards being determined with a greater bias as they grow
Linear regression for microCT, 18F-FDG-PET and caliper determined tumor volume against reference tumor volume Figure 1
Linear regression for microCT, 18F-FDG-PET and caliper determined tumor volume against reference tumor 
volume. Best lines were: y = 1.01x - 6.1 (R2 = 0.97) for microCT versus reference volume, y = 1.24x + 15.4 (R2 = 0.75) for 
18F-FDG-PET versus reference volume and y = 1.27x + 56.9 (R2 = 0.80) for caliper versus reference volume.
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larger. The bias in PET measurements was not dependent
on tumor size.
Intra-observer variation on the microCT measurements
was substantially lower compared to variation on the cal-
iper measurements. In consequence, microCT measure-
ments will allow for detection of smaller changes and
earlier recognition of efficacy in subcutaneous xenografts
during experimental cancer treatment studies than stand-
ard external caliper. Further, it will allow for reduction in
the number of animals necessary to show a given effect in
cancer treatment studies e.g. when testing new anticancer
drugs.
Previous, analysis of intra-observer variation of caliper
measurements have been carried out. CV was 12% for a
small (320 mm3) and 6% for a larger (1450 mm3) tumor
[1]. Using even smaller tumors (70–90 mm3) we found
CV to be 14% for the caliper method and accordingly
overlooking effects during longitudinal treatment studies
can be marked with this method. In contrast, in the
present study, where small tumors were used for the intra-
observer variation, we fund a CV for microCT measure-
ments as low as 7%. MicroCT hence allows detection of
small changes in much smaller tumors than the tradi-
tional caliper.
Tumor volume was determined with a rather high repro-
ducibility between observers by both the microCT and cal-
iper methods. Variation between observers for microCT
measurements in this study was comparable to a study of
much greater tumors in rats [12], however the current
study has showed that the low inter-observer variation of
the microCT method is also valid for small tumors.
Volume determination by the caliper method was inaccu-
rate with a significant bias that increased with tumor size.
Very likely, this inaccuracy is partly due to the assumption
that all tumors have shape like a modified ellipsoid,
which may be less true for large tumors. With the microCT
method, bias that arises from assumption of this specific
geometry is removed. In consequence, tumor volume is
accurately determined irrespective of tumor size and form.
Tumor volume measured by microPET did not correlate
well with true tumor volume. In order to determine tumor
size by 18F-FDG-PET, all parts of the tumor must take up
18F-FDG. Visual inspection of PET images in this study
(figure 2) showed a heterogeneous 18F-FDG uptake in the
tumors, which made it difficult accurately to identify
tumor boundary. The resolution of the microPET images
was not as high as of the microCT images which also con-
tributed to the much lower accuracy of the PET volume
data. Therefore, it was not unexpected that 18F-FDG-PET
Transverse section of a representative 18F-FDG-PET (A) and microCT (B) image of a mouse with a subcutaneous tumor Figure 2
Transverse section of a representative 18F-FDG-PET (A) and microCT (B) image of a mouse with a subcutane-
ous tumor. Tumor is indicated by a white arrow and ROIs are drawn separately in the PET and microCT picture.
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Bland-Altman plots comparing three methods for measurement of tumor volume of subcutaneous mouse xenografts with the  reference volume Figure 3
Bland-Altman plots comparing three methods for measurement of tumor volume of subcutaneous mouse 
xenografts with the reference volume. The central line (mean) indicates the bias and the outer lines (± 2SD) indicate the 
limits of agreement (LoA).
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was unsuitable for determination of tumor volume and
consequently  18F-FDG-PET is rarely used for volume
measurements. As the current study showed that the
microCT method accurately and precisely identified
tumor volumes, identification of tumors based on the
anatomically CT image and subsequently fusion of PET
and CT images will allow much more precise determina-
tion of tracer uptake. Accordingly, a combination of
microCT with microPET will allow a sensitive and accu-
rate quantification of tumor burden in mice and be valu-
able for the evaluation of novel cancer treatments.
Conclusion
In summary, the present study demonstrated that
microCT was more accurate than both external caliper
measurements and 18F-FDG-microPET for in vivo volu-
metric measurements of subcutaneous tumors in
mice.18F-FDG-microPET was considered unsuitable for
determination of tumor size. External caliper were inaccu-
rate and encumbered with a significant and size depend-
ent bias. External caliper are, despite this inaccuracy,
currently the standard method for determination of
tumor volume due to the low cost and high throughput of
the simple method. In contrast, we found that microCT
was accurate, without systematic bias and more reproduc-
ible than caliper measurements. Consequently, microCT
is a promising method that should be used when studies
of small changes in experimental cancer treatment studies
of subcutaneous tumors in mice is needed.
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Correlation of tumor volume determined by two different observers measured by caliper and microCT respectively Figure 4
Correlation of tumor volume determined by two different observers measured by caliper and microCT 
respectively. Tumor volumes measures by the two observers were plotted and correlations were evaluated by means of lin-
ear fitting and correlation coefficients (R2). Best line was y = 0.98x - 7.4 (R2 = 0.91) for caliper and y = 1.01x - 0.65 (R2 = 0.97) 
for microCT measurements.
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Bland-Altman plots of the difference between two observers against mean tumor volume Figure 5
Bland-Altman plots of the difference between two observers against mean tumor volume. The central line (mean) 
indicates the bias and the outer lines (± 2SD) indicate the limits of agreement (LoA).
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